Related Experiment Video
Updated: Jan 4, 2026

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
A Shifty Target: Tumor-Initiating Cells and Their Metabolism
Nicole Bezuidenhout1, Maria Shoshan2
1Department of Oncology-Pathology, Karolinska Institute, 171 64 Stockholm, Sweden. nicole.bezuidenhout@ki.se.
Abstract:
Tumor-initiating cells (TICs), or cancer stem cells, constitute highly chemoresistant, asymmetrically dividing, and tumor-initiating populations in cancer and are thought to play a key role in metastatic and chemoresistant disease. Tumor-initiating cells are isolated from cell lines and clinical samples based on features such as sphere formation in stem cell medium and expression of TIC markers, typically a set of outer membrane proteins and certain transcription factors. Although both bulk tumor cells and TICs show an adaptive metabolic plasticity, TIC metabolism is thought to differ and likely in a tumor-specific and growth condition-dependent pattern. In the context of some common solid tumor diseases, we here review reports on how TIC isolation methods and markers associate with metabolic features, with some focus on oxidative metabolism, including fatty acid and lipid metabolism. These have emerged as significant factors in TIC phenotypes, and in tumor biology as a whole. Other sections address mitochondrial biogenesis and dynamics in TICs, and the influence of the tumor microenvironment. Further elucidation of the complex biology of TICs and their metabolism will require advanced methodologies.
Insights
Tumor-initiating cells (TICs) are chemoresistant cancer stem cells crucial for metastasis. Their unique metabolism, particularly oxidative processes, is key to their function and requires advanced study.
Area of Science:
- Oncology
- Cancer Biology
- Metabolic Research
Background:
- Tumor-initiating cells (TICs), also known as cancer stem cells, are implicated in cancer metastasis and chemoresistance.
- TICs are identified by sphere formation and specific cell surface markers.
- While TICs exhibit metabolic plasticity, their metabolic profile differs from bulk tumor cells and varies by tumor type and growth conditions.
Purpose of the Study:
- To review the association between TIC isolation methods, markers, and metabolic features in common solid tumors.
- To highlight the role of oxidative metabolism, including fatty acid and lipid metabolism, in TIC phenotypes.
- To discuss mitochondrial biogenesis, dynamics, and the tumor microenvironment's influence on TICs.
Main Methods:
- Literature review of studies on TIC isolation, markers, and metabolism.
- Focus on oxidative metabolism, fatty acid, and lipid metabolism in TICs.
- Examination of mitochondrial aspects and the tumor microenvironment's impact.
Main Results:
- TIC isolation methods and markers correlate with distinct metabolic characteristics.
- Oxidative metabolism, fatty acid, and lipid metabolism are significant factors in TIC phenotypes and overall tumor biology.
- Mitochondrial function and the tumor microenvironment play crucial roles in TIC biology.
Conclusions:
- Understanding TIC metabolism is vital for targeting chemoresistant and metastatic cancers.
- Advanced methodologies are necessary to fully elucidate the complex biology and metabolism of TICs.
- Metabolic targeting of TICs represents a promising therapeutic strategy.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

